1 Table of Contents
2 Introduction_x000D_
2.1 What Is This Report About?_x000D_
2.2 Intraocular Lens (IOL) Market Segmentation_x000D_
2.3 Definitions of Markets Covered in the Report_x000D_
3 Intraocular Lens (IOL) Market, North America_x000D_
3.1 Intraocular Lens (IOL) Market, North America, Revenue ($m), 2018-2033_x000D_
3.2 Intraocular Lens (IOL) Market, North America, Revenue ($m), 2018-2033_x000D_
3.3 Intraocular Lens (IOL) Market, North America, Volume (Units), 2018-2033_x000D_
3.4 Intraocular Lens (IOL) Market, North America, Volume (Units), 2018-2033_x000D_
3.5 Intraocular Lens (IOL) Market, North America, Company Share by Revenue ($m), 2024_x000D_
4 Intraocular Lens (IOL) Market, Canada_x000D_
4.1 Intraocular Lens (IOL) Market, Canada, Revenue ($m), 2018-2033_x000D_
4.1.1 Foldable IOL Market, Canada, Revenue ($m), by Segment, 2018-2033_x000D_
4.2 Intraocular Lens (IOL) Market, Canada, Volume (Units), 2018-2033_x000D_
4.2.1 Foldable IOL Market, Canada, Volume (Units), by Segment, 2018-2033_x000D_
4.3 Intraocular Lens (IOL) Market, Canada, Average Price ($), 2018-2033_x000D_
4.4 Intraocular Lens (IOL) Market, Canada, Company Share by Revenue ($m), 2024_x000D_
5 Intraocular Lens (IOL) Market, Mexico_x000D_
5.1 Intraocular Lens (IOL) Market, Mexico, Revenue ($m), 2018-2033_x000D_
5.1.1 Foldable IOL Market, Mexico, Revenue ($m), by Segment, 2018-2033_x000D_
5.2 Intraocular Lens (IOL) Market, Mexico, Volume (Units), 2018-2033_x000D_
5.2.1 Foldable IOL Market, Mexico, Volume (Units), by Segment, 2018-2033_x000D_
5.3 Intraocular Lens (IOL) Market, Mexico, Average Price ($) , 2018-2033_x000D_
5.4 Intraocular Lens (IOL) Market, Mexico, Company Share by Revenue ($m), 2024_x000D_
6 Intraocular Lens (IOL) Market, United States_x000D_
6.1 Intraocular Lens (IOL) Market, United States, Revenue ($m), 2018-2033_x000D_
6.1.1 Foldable IOL Market, United States, Revenue ($m), by Segment, 2018-2033_x000D_
6.2 Intraocular Lens (IOL) Market, United States, Volume (Units), 2018-2033_x000D_
6.2.1 Foldable IOL Market, United States, Volume (Units), by Segment, 2018-2033_x000D_
6.3 Intraocular Lens (IOL) Market, United States, Average Price ($) , 2018-2033_x000D_
6.4 Intraocular Lens (IOL) Market, United States, Company Share by Revenue ($m), 2024_x000D_
7 Overview of Key Companies in North America Intraocular Lens (IOL) Market_x000D_
7.1 Alcon Inc_x000D_
7.1.1 Company Overview_x000D_
7.2 Johnson & Johnson Vision Care Inc_x000D_
7.2.1 Company Overview_x000D_
7.3 Bausch & Lomb Inc_x000D_
7.3.1 Company Overview_x000D_
7.4 Carl Zeiss Meditec AG_x000D_
7.4.1 Company Overview_x000D_
7.5 Hoya Corp_x000D_
7.5.1 Company Overview_x000D_
8 Intraocular Lens (IOL) Market Pipeline Products_x000D_
9 Recent Developments_x000D_
9.1 Corporate Communications_x000D_
9.1.1 Nov 07, 2025: STAAR Surgical Amends Alcon Merger Agreement_x000D_
9.1.2 Oct 16, 2025: STAAR Surgical Confirms No Acquisition Proposals Other Than Alcon_x000D_
9.1.3 Oct 10, 2025: Broadwood Partners Issues Letter To STAAR Surgical’s Board Questioning Its Diligence In Rush To Reaffirm Support For Alcon Sale_x000D_
9.1.4 Oct 09, 2025: Abbott And Abbott Fund Support Northern Illinois Food Bank With $250,000 Grant To Address Childhood Hunger_x000D_
9.1.5 Sep 16, 2025: STAAR Surgical Board Confirms Alcon Merger as Best Value for Stockholders_x000D_
9.1.6 Sep 12, 2025: Ocumetics Engages The Howard Group for Investment Communications_x000D_
9.1.7 Sep 02, 2025: Jennifer Kang-Mieler Named Director of the Semcer Center for Healthcare Innovation_x000D_
9.2 Financial Announcements_x000D_
9.2.1 Sep 30, 2025: Bausch Health to Announce Third Quarter 2025 Results on October_x000D_
9.2.2 Feb 11, 2025: STAAR Surgical Reports Fourth Quarter and Fiscal Year 2024 Results_x000D_
9.2.3 Jan 22, 2025: Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2024 Financial Results on February_x000D_
9.2.4 Jan 13, 2025: STAAR Surgical to Host Fourth Quarter and Fiscal Year 2024 Earnings Conference Call and Webcast on February 19, 2025_x000D_
9.3 Government and Public Interest_x000D_
9.3.1 Aug 14, 2025: RxSight to Present at the Wells Fargo Healthcare Conference_x000D_
9.3.2 Nov 25, 2024: STAAR Surgical to Participate in BTIG Ophthalmology Day_x000D_
9.4 Legal And Regulatory_x000D_
9.4.1 Sep 22, 2025: Yunqi Capital, 5.1% Holder of STAAR Surgical, Announces Opposition to Sale to Alcon_x000D_
9.4.2 Apr 23, 2025: Novo Nordisk to discontinue Human Mixtard, India's largest selling insulin brand_x000D_
9.5 Other Significant Developments_x000D_
9.5.1 Sep 22, 2025: Yunqi Capital, 5.1% Holder of STAAR Surgical, Announces Opposition to Sale to Alcon_x000D_
9.5.2 Sep 12, 2025: Ocumetics Engages The Howard Group for Investment Communications_x000D_
9.5.3 May 29, 2025: Addtronics Strengthens Medical Device Automation Capabilities with Addition of DAC International_x000D_
9.6 Product News_x000D_
9.6.1 Nov 10, 2025: SpyGlass Pharma Reports Positive Results from BIM-IOL System Trials_x000D_
9.6.2 Oct 30, 2025: Revolutionary Cataract Surgery Technology Transforms Eye Care with Precision and Enhanced Patient Outcomes_x000D_
9.6.3 Oct 17, 2025: Lumetrics Wavefront Sensors_x000D_
9.6.4 Oct 14, 2025: SpyGlass Pharma’s BIM-IOL System Shows Significant IOP Reduction at 24 Months_x000D_
9.6.5 Oct 14, 2025: BVI’s Finevision HP Receives FDA Approval for Advanced Trifocal IOLs_x000D_
9.6.6 Oct 13, 2025: Johnson & Johnson Celebrates Milestone of 100K TECNIS ODYSSEY IOLs Implanted at the 2025 American Academy of Ophthalmology Annual Meeting_x000D_
9.6.7 Oct 06, 2025: Samsara Vision Announces First Pseudophakic Surgery in the PERSPECTIVE Clinical Trial_x000D_
9.6.8 Sep 26, 2025: STAAR Surgical Publishes Presentation Highlighting Compelling, Certain Cash Value Offered by Alcon Merger and Meaningful Downside Risks if Alcon Merger Is Not Approved_x000D_
9.6.9 Sep 16, 2025: Ocumetics Completes One-Month Postoperative Examinations_x000D_
9.6.10 Sep 11, 2025: K8 Implant From Inflammasome Therapeutics Reduces Lesion Growth in Geographic Atrophy_x000D_
9.6.11 Apr 23, 2025: EyeCare Partners Presents Latest Innovations in Eye Care at the American Society of Cataract and Refractive Surgery (ASCRS) 2025 in Los Angeles_x000D_
9.7 Strategy And Business Planning_x000D_
9.7.1 Sep 12, 2025: Ocumetics Engages The Howard Group for Investment Communications_x000D_
9.7.2 Sep 02, 2025: Jennifer Kang-Mieler Named Director of the Semcer Center for Healthcare Innovation_x000D_
10 Appendix_x000D_
10.1 Research Methodology_x000D_
10.1.1 Coverage_x000D_
10.1.2 Secondary Research_x000D_
10.1.3 Primary Research_x000D_
10.1.4 Market Modeling and Forecasting_x000D_
10.1.5 Company Share Analysis_x000D_
10.1.6 Benchmarking_x000D_
10.2 GlobalData Consulting_x000D_
10.3 Contact Us_x000D_
10.4 Disclaimer